Correlation Between All Iron and Oryzon Genomics

Can any of the company-specific risk be diversified away by investing in both All Iron and Oryzon Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining All Iron and Oryzon Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between All Iron Re and Oryzon Genomics SA, you can compare the effects of market volatilities on All Iron and Oryzon Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in All Iron with a short position of Oryzon Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of All Iron and Oryzon Genomics.

Diversification Opportunities for All Iron and Oryzon Genomics

-0.74

Correlation Coefficient

All Iron  Oryzon Genomics

Pay attention - limited upside

The 3 months correlation between All and Oryzon is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding All Iron Re and Oryzon Genomics SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oryzon Genomics SA and All Iron is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on All Iron Re are associated (or correlated) with Oryzon Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oryzon Genomics SA has no effect on the direction of All Iron i.e., All Iron and Oryzon Genomics go up and down completely randomly.

Pair Corralation between All Iron and Oryzon Genomics

Assuming the 90 days trading horizon All Iron Re is expected to generate 0.35 times more return on investment than Oryzon Genomics. However, All Iron Re is 2.87 times less risky than Oryzon Genomics. It trades about 0.26 of its potential returns per unit of risk. Oryzon Genomics SA is currently generating about -0.1 per unit of risk. If you would invest  1,050  in All Iron Re on October 11, 2024 and sell it today you would earn a total of  50.00  from holding All Iron Re or generate 4.76% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

All Iron Re  vs.  Oryzon Genomics SA

All Iron Re

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in All Iron Re are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, All Iron may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Oryzon Genomics SA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Oryzon Genomics SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with All Iron and Oryzon Genomics

The main advantage of trading using opposite All Iron and Oryzon Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if All Iron position performs unexpectedly, Oryzon Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oryzon Genomics will offset losses from the drop in Oryzon Genomics' long position.

The idea behind All Iron Re and Oryzon Genomics SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.